News

Pharmabiz20m

REGENXBIO to initiate pivotal phase IIb/III clinical trial of surabgene lomparvovec in diabetic retinopathy

REGENXBIO Inc. announced it will initiate a pivotal phase IIb/III clinical trial for investigational surabgene lomparvovec (sura-vec, ABBV-RGX-314) in diabetic retinopathy (DR) using suprachoroidal ...
Pharmabiz35m

Primelaze introduces revolutionary German Q-Switched Nd: YAG technology, a game-changer for comprehensive range of skin treatments

YAG technology, a game-changer for comprehensive range of skin treatments: Our Bureau, Mumbai Friday, August 8, 2025, 14:4 ...
Pharmabiz50m

Philips India introduces Philips Avent Hands-free Electric Breast Pump on the occasion of World Breastfeeding Week

Our Bureau, Mumbai Friday, August 8, 2025, 14:30 Hrs [IST] ...
Pharmabiz1h

Intas Pharma & Accord BioPharma become one of the largest global suppliers of pegfilgrastim with acquisition of Udenyca

Our Bureau, Mumbai Friday, August 8, 2025, 14:15 Hrs [IST] ...
Pharmabiz1h

CorMedix to acquire biopharma company, Melinta Therapeutics in $300 million deal

CorMedix to acquire biopharma company, Melinta Therapeutics in $300 million deal: Berkeley Heights, New Jersey Friday, August 8, 2025, 14:00 Hrs [IST] CorMedix Inc. (CorMedix), a ...
Pharmabiz1h

Biocon net profit down 95 per cent in Q1FY26

Our Bureau, New Delhi Friday, August 8, 2025, 13:30 Hrs [IST] Biopharmaceutical major Biocon Ltd has reported a 95 per cent decline i ...
Pharmabiz2h

Cartherics opens state-of-the-art cleanroom facility for clinical-scale manufacturing of cell therapy products

Cartherics opens state-of-the-art cleanroom facility for clinical-scale manufacturing of cell therapy products: Melbourne, Australia Friday, August 8, 2025, 13:00 Hrs [IST] Melbou ...
Pharmabiz3h

Cardiol Therapeutics reports topline results from phase II ARCHER trial of CardiolRx in acute myocarditis patients

Cardiol Therapeutics reports topline results from phase II ARCHER trial of CardiolRx in acute myocarditis patients: Toronto, Ontario Friday, August 8, 2025, 12:00 Hrs [IST] Cardio ...
Pharmabiz4h

US FDA approves Jazz Pharmaceuticals’ Modeyso to treat recurrent H3 K27M-mutant diffuse midline glioma

US FDA approves Jazz Pharmaceuticals’ Modeyso to treat recurrent H3 K27M-mutant diffuse midline glioma: Dublin Friday, August 8, 2025, 11:00 Hrs [IST] Jazz Pharmaceuticals plc, ...
Pharmabiz5h

Freenome enters exclusive license agreement with Exact Sciences to commercialize Freenome’s blood-based screening test for colorectal cancer

Brisbane, California Friday, August 8, 2025, 10:00 Hrs [IST] ...
Pharmabiz6h

Eli Lilly announces positive results from phase 3 ATTAIN-1 trial of orforglipron, an oral GLP-1 receptor agonist to treat obesity

Eli Lilly announces positive results from phase 3 ATTAIN-1 trial of orforglipron, an oral GLP-1 receptor agonist to treat obesity: Indianapolis Friday, August 8, 2025, 09:00 Hrs [ ...
Pharmabiz7h

NPPA accepts MDC's decision to reject Dr Reddy's application on separate price for Omaze ODT

Gireesh Babu, New Delhi Friday, August 8, 2025, 08:00 Hrs [IST] ...